Stephen Mullennix

Overview

Stephen Mullennix received an average of $2M in total compensation, including $312K in salary, at UroGen Pharma Ltd. from 2018 to 2020.

Source: SEC filings on April 28, 2021, April 29, 2020, and April 26, 2019.

Related executives

We found ten more executives who work or worked at UroGen Pharma Ltd..

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

Jason Smith

UroGen Pharma Ltd.

General Counsel

Don Kim

UroGen Pharma Ltd.

Chief Financial Officer

Molly Henderson

UroGen Pharma Ltd.

Chief Financial Officer

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

Gil Hakim

UroGen Pharma Ltd.

Former President

News

You may also like